(Q47928900)

6 February 2018

title

Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome (English)

1 reference

6 February 2018

1 reference

acute myeloid leukemia

1 reference

7

1 reference

6 February 2018

Lorenzo Galluzzi

9

object named as

L Galluzzi

1 reference

6 February 2018

18

G Kroemer

1 reference

6 February 2018

17

P Fenaux

1 reference

6 February 2018

author name string

S Boehrer

1

1 reference

6 February 2018

L Adès

2

1 reference

6 February 2018

N Tajeddine

3

1 reference

6 February 2018

W K Hofmann

4

1 reference

6 February 2018

S Kriener

5

1 reference

6 February 2018

G Bug

6

1 reference

6 February 2018

M Ruthardt

8

1 reference

6 February 2018

C Fouassier

10

1 reference

6 February 2018

M Tailler

11

1 reference

6 February 2018

K A Olaussen

12

1 reference

6 February 2018

C Gardin

13

1 reference

6 February 2018

V Eclache

14

1 reference

6 February 2018

S de Botton

15

1 reference

6 February 2018

S Thepot

16

1 reference

6 February 2018

language of work or name

English

0 references

publication date

27 April 2009

1 reference

6 February 2018

published in

Oncogene

1 reference

6 February 2018

volume

28

1 reference

6 February 2018

issue

22

1 reference

6 February 2018

page(s)

2205-2218

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1038/onc.2009.69

exact match

0 references

cites work

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

DNA damage signalling guards against activated oncogenes and tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

ATM activation in normal human tissues and testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Quantitation of mitochondrial alterations associated with apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Enrichment of non-synchronized cells in the G1, S and G2 phases of the cell cycle for the study of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

ATM activation is accompanied with earlier stages of prostate tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

H2AX: the histone guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Cell death modalities: classification and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Cell-cycle checkpoints and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Caspases disrupt mitochondrial membrane barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Excessive apoptosis in low risk myelodysplastic syndromes (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

The role of apoptosis in the pathogenesis of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Methods to measure membrane potential and permeability transition in the mitochondria during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Bid acts on the permeability transition pore complex to induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.69

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.69

1 reference

6 February 2018

1 reference

6 February 2018